Amyloid PET/CT

Amyloid PET/CT imaging is an advanced diagnostic tool used to detect amyloid plaque buildup in the brain—a key indicator associated with Alzheimer’s disease and other cognitive disorders.

This scan is particularly valuable for patients experiencing memory loss or cognitive decline, helping physicians distinguish Alzheimer’s disease from other forms of dementia. By providing clear visualization of amyloid deposits, Amyloid PET/CT supports:

• Earlier and more accurate diagnosis
• Improved differentiation between neurological conditions
• More informed treatment planning and patient management

PSMA PET/CT

PSMA PET/CT imaging is a highly sensitive diagnostic scan used in the detection and management of prostate cancer. It utilizes a specialized radiotracer that targets Prostate-Specific Membrane Antigen (PSMA), a protein commonly found on prostate cancer cells.

This advanced imaging technology is especially effective in identifying:

• Cancer recurrence, even at very low PSA levels
• Metastatic disease (cancer spread)
• Precise location of prostate cancer within the body

By delivering highly detailed imaging, PSMA PET/CT enables physicians to make more informed, personalized treatment decisions, improving outcomes for patients at every stage of care.

Cardiac PET/CT

Cardiac PET/CT imaging is a non-invasive test used to evaluate blood flow to the heart muscle and assess overall cardiac function. It is commonly performed to detect and manage conditions such as coronary artery disease.

This advanced imaging technique helps physicians:

• Identify reduced blood flow or blockages in the heart
• Assess myocardial viability (heart muscle health)
• Evaluate patients with known or suspected heart disease

Cardiac PET/CT provides highly accurate measurements, allowing for early detection of abnormalities, more precise diagnoses, and improved treatment planning—often reducing the need for invasive procedures.